HIGHLIGHTS
- who: Dick de Zeeuw from the Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Centre Groningen, De Brug, ‑1‑026, EB70, Postbox, RB Groningen, The Netherlands have published the research: The future of Diabetic Kidney Disease management: reducing the unmet need, in the Journal: (JOURNAL)
- what: This approach in drug development and drug registration for renal protection in type 2 diabetic patients has the rule that the drug and the required dose is developed for lowering of the single surrogate marker, the target. Trial design Given the high residual risk for progressive . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.